BIDICA Tablet

For the treatment of chronic an persistent hepatitis that is associated with a high ALT level or drug-induced high transaminase level.

Dosage and Administration

Adults: 1-2 tablets 3 times daily.

Nausea may occur rarely.

During administration of this drug, there are few patients who ALT rises again. ALT can increase after stopping administration, but it can be improved through re-administration of this drug.

If thirst, rash occurs, the patients should administer this drug with anti-hypersensitivity agent.

If temporary jaundice occurs, the patient should discontinue the administration or administer this drug with treatment for jaundice.

Nausea and abdominal distention can occur rarely but the symptoms are lost soon.

When this medicine is administered with inosine together, relapsed ALT’s rise can improve.

This drug should not be administered to pregnant and nursing mother.

This medicine should be used with caution in patients with chronic active hepatitis and cirrhosis.

This drug should be administered to young child in reduced dosage.

Usually, the aged is administered carefully reducing the quantity because their physiology has been depreciated.